Davis Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Davis Investment Partners's LLY Position: Q2 2026 in Review
Davis Investment Partners increased its Eli Lilly (LLY) stake by 3.1% in Q2 2026, buying an estimated $37.8K and bringing the position to 1,243 shares worth $1.49M. The position accounts for 0.45% of the portfolio, ranked #40.
Davis Investment Partners first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Davis Investment Partners held 1,243 shares of Eli Lilly worth $1.49M as of Q2 2026.
- Davis Investment Partners bought 37 Eli Lilly shares in Q2 2026, an estimated $37.8K.
- Eli Lilly made up 0.45% of Davis Investment Partners's portfolio in Q2 2026, its #40 holding.
- Davis Investment Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Davis Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.